EVALUATION OF RISK FACTORS IN PATIENTS WITH ACUTE CORONARY SYNDROME WITH ST SEGMENT ELEVATION AND WITHOUT ST SEGMENT ELEVATION

Svrha istraživanja: Cilj ovog istraživanja jest analizirati čimbenike rizika u bolesnika sa STE-ACS i bolesnika s NSTE-ACS. Ispitanici i metode: U ovo presječno istraživanje je uključeno 37 ispitanika s akutnim koronarnim sindromom koji su liječeni u Klinici za kardiologiju Kliničkog bolničkog centra Split. Podatci o ispitanicima prikupljeni su iz anketnih upitnika. Ispitanici su podijeljeni u dvije skupine: 19 bolesnika u skupini STE-ACS te 18 bolesnika u skupini NSTE-ACS. Rezultati: U ovom istraživanju između skupina bolesnika sa STE-ACS i NSTE-ACS nije bilo statistički značajne razlike u zastupljenosti prema spolu (P=0.749), dobi (P=0.88) i nije bilo značajne razlike u prosječnoj vrijednosti indeksa tjelesne mase (P=0.347). Nadalje, skupine ispitanika sa STE–ACS i NSTE-ACS nisu se statistički razlikovale u zastupljenosti arterijske hipertenzije (P=0.50), šećerne bolesti (P=0.08), displipidemije (P=0.94) i pušenja (P=0.13). Zaključak: Ovo istraživanje je pokazalo da bolesnici liječeni zbog STE-ACS značajno se ne razlikuju od bolesnika s NSTE-ACS prema dobi, spolu i indeksu tjelesne mase. Bolesnici sa STE-ACS nemaju značajno veću zastupljenost arterijske hipertenzije, šećerne bolesti, displipidemije i pušača u odnosu na bolesnika s NSTE-ACS.Objectives: The purpose of this study was to evaluate risk factors in patients with acute coronary syndrome with ST segment elevation and without ST segment elevation. Materials and methods: This cross-sectional study included 37 patients with acute coronary syndrome treated at Department of cardiology of University Hospital of Split. Personal data were collected from poll. Patients were divided in two groups: 19 in STE-ACS group and 18 in NSTE-ACS group. Results: In this study there was no statistical difference between groups by sex (P=0.749), age (P=0.88) and there was no statistical difference in average value of body mass index (P=0.347). Furthermore, STE-ACS and NSTE-ACS groups had no statistical differences in prevalence of: arterial hypertension (P=0.50), diabetes (P=0.08), dyslipidemia (P=0.94) and smoking (P=0.13). Conclusion: This study showed that patients treated from STE-ACS are not statistically different from patients treated from NSTE-ACS by: age, sex and body mass index. Patients with STE-ACS have no statistically bigger prevalence of: arterial hypertension, diabetes, dyslipidemia and smoking in relation with patients with NSTE-ACS